Insider Transactions in Q3 2018 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2018
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
49,799
-45.69%
|
$4,830,503
$97.93 P/Share
|
|
Sep 24
2018
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,799
+20.42%
|
$1,792,764
$36.85 P/Share
|
|
Sep 14
2018
|
Omar Ishrak Executive Chairman |
BUY
Bona fide gift
|
Indirect |
10,000
+50.0%
|
-
|
|
Sep 14
2018
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Direct |
10,000
-1.77%
|
-
|
|
Sep 07
2018
|
Omar Ishrak Executive Chairman |
BUY
Bona fide gift
|
Direct |
4,580
+0.8%
|
-
|
|
Sep 07
2018
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Indirect |
4,580
-37.56%
|
-
|
|
Aug 31
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
26,159
-29.46%
|
$2,511,264
$96.29 P/Share
|
|
Aug 31
2018
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
26,159
+9.09%
|
$1,621,858
$62.76 P/Share
|
|
Aug 28
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
47,176
-30.92%
|
$4,481,720
$95.88 P/Share
|
|
Aug 28
2018
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
41,227
+21.27%
|
$1,566,626
$38.81 P/Share
|
|
Aug 23
2018
|
Robert C Pozen Director |
SELL
Open market or private sale
|
Direct |
3,218
-5.01%
|
$305,710
$95.94 P/Share
|
|
Aug 23
2018
|
Robert C Pozen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,484
+3.43%
|
$165,908
$37.05 P/Share
|
|
Aug 23
2018
|
Richard H Anderson Director |
BUY
Open market or private purchase
|
Direct |
2,600
+3.27%
|
$247,000
$95.88 P/Share
|
|
Aug 22
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Open market or private sale
|
Direct |
145,544
-42.1%
|
$13,826,680
$95.5 P/Share
|
|
Aug 22
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Exercise of conversion of derivative security
|
Direct |
178,219
+17.24%
|
$6,772,322
$38.52 P/Share
|
|
Aug 03
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
7,585
-4.33%
|
$682,650
$90.48 P/Share
|
|
Aug 03
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
4,822
-7.15%
|
$433,980
$90.48 P/Share
|
|
Aug 03
2018
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
27,010
-4.59%
|
$2,430,900
$90.48 P/Share
|
|
Aug 03
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,987
-4.29%
|
$448,830
$90.48 P/Share
|
|
Aug 03
2018
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,818
-9.17%
|
$523,620
$90.48 P/Share
|
|
Aug 03
2018
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,780
-7.47%
|
$430,200
$90.48 P/Share
|
|
Aug 03
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,156
-8.91%
|
$374,040
$90.48 P/Share
|
|
Aug 03
2018
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,954
-5.56%
|
$355,860
$90.48 P/Share
|
|
Aug 03
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,806
-5.41%
|
$252,540
$90.48 P/Share
|
|
Aug 01
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-0.4%
|
$18,630
$90.24 P/Share
|
|
Jul 30
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
16,465
+8.6%
|
-
|
|
Jul 30
2018
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
9,355
+12.34%
|
-
|
|
Jul 30
2018
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
50,517
+7.9%
|
-
|
|
Jul 30
2018
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,104
+7.99%
|
-
|
|
Jul 30
2018
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,226
+15.03%
|
-
|
|
Jul 30
2018
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,226
+14.93%
|
-
|
|
Jul 30
2018
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,089
+14.92%
|
-
|
|
Jul 30
2018
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,233
+15.0%
|
-
|
|
Jul 30
2018
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
9,730
+12.04%
|
-
|
|
Jul 30
2018
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
10,478
+16.75%
|
-
|
|
Jul 28
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
10,038
-14.95%
|
$883,344
$88.66 P/Share
|